The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
Advances in autologous treatment and mobilization in lymphoma
Can a epoetin biosimilar be used to treat chemotherapy-induced anemia?
FCR or FR – which regimen is better for treating CLL?
What’s next for rare myelomas?